Comprehensive Study Guide to the Complement System: Pathways, Regulation, and Biological Functions

Overview, Historical Context, and General Characteristics of the Complement System

Definition and Core Role:
- The complement system is an enzymatic cascade of the innate immune system whose primary biological function is the lysis of pathogenic targets, including Gram-negative bacteria, enveloped viruses, and target eukaryotic cells.
- It acts in concert with, and augments, the inflammatory response and antibody-mediated defense mechanisms.
Historical Discovery and Nomenclature:
- Characterized during the late 19th century as a functional activity present in fresh serum capable of lysing bacteria in "complement" to the bactericidal action of specific antibodies ( $\text{Abs}$ ).
- Its individual protein components are numbered historically according to the order of their discovery, rather than the chronological sequence of their activation in the enzymatic cascade.
Physicochemical Properties and Composition:
- Thermolability: Complement components are heat-labile proteins. Incubation of serum at $56\,^\circ\text{C}$ completely heat-inactivates complement activity, preventing complement-mediated cell lysis. This inactivation step is critical in cell culture protocols to eliminate non-specific serum toxicity.
- Circulating Abundance: The system consists of $30\text{ to }35$ distinct soluble proteins that circulate abundantly in the bloodstream and other biological fluids.
- Sites of Synthesis: Circulating complement proteins are synthesized predominantly by hepatocytes in the liver, with secondary local synthesis by monocytes, tissue macrophages, and epithelial cells.
- The Central Component ( $C3b$ ): The cleaved fragment $C3b$ is the core pivot of the entire system; without its activation and stabilization, downstream cascade propagation and amplification cease.
Evolutionary Lineage and Activation Timeline:
- The complement system represents an ancestral immune defense mechanism that appeared very early in metazoan evolution, well before the emergence of immunoglobulins and adaptive immunity.
- During an infectious event, activation pathways are recruited chronologically:
  - 1. Alternative Pathway: Triggered immediately and spontaneously upon pathogen surface contact (antibody-independent innate defense).
  - 1'. Lectin Pathway (MBP Pathway): Activated rapidly thereafter via direct pattern recognition of pathogen surface carbohydrates (antibody-independent innate defense).
  - 2. Classical Pathway: Activated last, as it is strictly dependent on the prior formation of specific antigen-antibody ( $\text{Ag-Ab}$ ) immune complexes, serving as a functional bridge between innate and adaptive immunity.

Overview of complement activation pathways, cleavage products, and biological effector outcomes

Functional Protein Groups:
- Activation Cascade Proteins: Circulate as inactive precursor coenzymes (zymogens) lacking enzymatic activity. Activation occurs via precise, sequential proteolytic cleavage by serine esterases. Each cleavage typically generates two fragments:
  - Larger "b" fragment: Generally binds covalently to target cell membranes or associates with convertase complexes to continue downstream activation.
  - Smaller "a" fragment: Generally diffuses away as a soluble mediator into the surrounding fluid phase, exerting pro-inflammatory and chemotactic functions.
- Regulatory Proteins: Soluble or membrane-bound inhibitory molecules that tightly restrict complement activation and protect autologous (self) host tissues from collateral lytic damage.
- Complement Receptors: Predominantly cell-surface membrane receptors that bind cleaved complement fragments to mediate phagocytosis, immune clearance, and cell signaling.

Molecular Mechanisms of the Three Activation Pathways

Convergence on C3 Convertase:
- Although the three activation cascades differ in their initiation triggers and early biochemical steps, all three pathways converge on the formation of a surface-bound enzymatic complex known as $C3\text{ convertase}$ .
- The enzymatic function of the $C3\text{ convertase}$ is to cleave native factor $C3$ , generating the reactive opsonin $C3b$ and the inflammatory mediator $C3a$ .

Comparative molecular assembly of the Classical, MBP, and Alternative complement pathways

The Classical Pathway:
- Initiator Complex ( $C1$ ): The pathway begins with the assembly of the macromolecular $C1$ complex, composed of three distinct proteins: one $C1q$ molecule complexed with two $C1r$ and two $C1s$ catalytic subunits in the presence of calcium ( $Ca^{2+}$ ).
- $C1q$ Subunit Architecture: $C1q$ is formed by six homologous protein subunits, each terminating in a globular head designed to interact directly with the constant ( $Fc$ ) regions of immunoglobulins.
- Antibody Requirements for Activation:
  - To trigger a productive conformational shift, at least two globular heads of a single $C1q$ molecule must simultaneously cross-link adjacent $Fc$ regions.
  - This requires either a minimum of two closely spaced surface-bound $\text{IgG}$ molecules or a single pentameric $\text{IgM}$ molecule bound to the target antigen. Consequently, activation requires an established specific adaptive immune response.
- Proteolytic Cascade of $C1$ :
  - Cross-linking of $C1q$ induces an allosteric conformational change that activates the intrinsic serine esterase activity of $C1r$ .
  - Active $C1r$ cleaves and activates $C1s$ , exposing its catalytic serine esterase site.
- Non-Immunological Triggers of $C1q$ : Independently of antibodies, $C1q$ can directly bind and become activated by specific substrates, including myelin sheaths, retroviruses, and mycoplasmas, contributing to broad non-specific recognition.
- Cleavage of $C4$ :
  - Active $C1s$ cleaves circulating native $C4$ into a small soluble fragment, $C4a$ , and a larger fragment, $C4b$ .
  - $C4b$ exposes an internal, highly reactive and unstable thioester bond ( $\text{S-CO}$ ). To stabilize, $C4b$ must rapidly form covalent bonds with nucleophilic hydroxyl or amine groups on the adjacent target pathogen membrane.
  - If $C4b$ fails to bind a membrane instantaneously, its exposed thioester reacts with water ( $H_2O$ ), irreversibly inactivating it into $iC4b$ . Inactivated $iC4b$ cannot participate in further convertase assembly, though it retains non-lytic inflammatory signaling functions.
- Cleavage of $C2$ and Formation of Classical $C3\text{ Convertase}$ :
  - Membrane-bound $C4b$ recruits native $C2$ in the presence of magnesium ( $Mg^{2+}$ ).
  - $C1s$ cleaves bound $C2$ into two fragments: the smaller $C2b$ fragment, which diffuses away into the fluid phase, and the larger $C2a$ fragment, which remains physically complexed with membrane-bound $C4b$ .
  - The resulting bimolecular surface complex $C4b2a$ constitutes the active $C3\text{ convertase}$ of the classical pathway.

Molecular activation cascade of the classical complement pathway

The Lectin Pathway (Mannose-Binding Lectin / MBP Pathway):
- Initiator Pattern Recognition Molecules: Operates completely independently of immunoglobulins. Initiation relies on soluble circulating lectins, primarily Mannose-Binding Lectin (MBL, synthesized by the liver), which recognizes arrays of mannose residues exposed on microbial surfaces.
- Alternative Soluble Receptors:
  - Ficolins: Structurally analogous multimeric proteins that bind $N\text{-acetylglucosamine}$ ( $\text{GlcNAc}$ ) on bacterial surfaces.
  - Collectins: Additional multimeric C-type lectins that recognize pathogen-associated microbial carbohydrates.
- Enzymatic Complex (MASPs): MBL is complexed with MBL-associated serine proteases: $MASP\text{-}1$ and $MASP\text{-}2$ , which are structural and functional homologues of $C1r$ and $C1s$ .
- Convertase Assembly:
  - Upon carbohydrate binding, active $MASP\text{-}2$ cleaves $C4$ into $C4a$ and $C4b$ , allowing $C4b$ to anchor covalently to the microbial surface.
  - $MASP\text{-}2$ sequentially cleaves $C2$ into $C2b$ and $C2a$ .
  - $C2a$ associates with surface-bound $C4b$ to assemble the functional $C3\text{ convertase}$ : $C4b2a$ (identical in subunit composition and enzymatic activity to that of the classical pathway).
The Alternative Pathway:
- Innate Surveillance Patrol: Acts as a continuous, antibody-independent immune sentinel in serum.
- Spontaneous Tick-Over (Fluid-Phase Hydrolysis): In aqueous biological fluid, circulating native $C3$ undergoes continuous, low-level spontaneous tick-over hydrolysis of its internal thioester bond, generating the active form of $C3$ ( $C3b$ or $C3(H_2O)$ ).
- Fate of Unbound vs. Bound $C3b$ :
  - Absence of pathogen surface: The exposed reactive thioester bond is rapidly quenched and hydrolyzed by water, inactivating the molecule and terminating the cascade prematurely to protect host fluid spaces.
  - Presence of activating pathogen surface: Cleaved $C3b$ covalently anchors to biological macromolecules on pathogen surfaces (such as lipopolysaccharides [LPS] on Gram-negative bacteria or viral envelope glycoproteins).
- Recruitment and Cleavage of Factor B:
  - Membrane-anchored $C3b$ binds circulating plasma Factor B ( $B$ ) in a $Mg^{2+}\text{-dependent}$ manner.
  - Bound Factor B changes conformation, exposing a cleavage site for circulating Factor D ( $D$ ), an active serine esterase functional homologue of $C1s$ .
  - Factor D cleaves Factor B into $Ba$ (a small soluble fragment that diffuses into the serum) and $Bb$ (the active catalytic fragment).
  - The active $Bb$ fragment remains non-covalently bound to $C3b$ , forming the bimolecular surface complex $C3bBb$ , which is the $C3\text{ convertase}$ of the alternative pathway.
- Stabilization by Properdin (Factor P):
  - The native $C3bBb$ convertase is intrinsically unstable, with a short half-life of approximately $5\text{ minutes}$ .
  - Plasma Properdin ( $P$ ) binds directly to $C3bBb$ , stabilizing the complex and extending its functional half-life six-fold, from $5\text{ minutes}$ to $30\text{ minutes}$ .
- The Amplification Loop: Once formed, alternative $C3\text{ convertases}$ ( $C3bBb$ ) continuously cleave native $C3$ , generating an avalanche of new $C3b$ fragments. Each newly bound $C3b$ recruits additional Factor B and Factor D, creating a massive self-reinforcing amplification loop that rapidly coats the pathogen surface.

Comparative convergence of Classical/Lectin and Alternative pathways on C3 and C5 convertases

The Central Role of Protein C3 and Terminal Assembly of the Membrane Attack Complex (MAC)

Biochemical Characteristics of Native C3:
- $C3$ is the central and most abundant complement protein in circulation, maintaining a plasma concentration of approximately $1.5\,\text{mg/mL}$ .
- It is a mature, inactive zymogen heterodimer consisting of an $\alpha\text{ chain}$ and a $\beta\text{ chain}$ covalently linked by interchain disulfide bridges.
- The $\alpha\text{ chain}$ harbors an internal, sequestered, and protected thioester bond in its native, stable state.
Cleavage and Activation Dynamics of C3:
- Proteolytic cleavage of native $C3$ by any $C3\text{ convertase}$ ( $C4b2a$ or $C3bBb$ ) releases a small peptide, $C3a$ , and unmasks a major conformational rearrangement in the $\alpha\text{ chain}$ of the remaining $C3b$ molecule.
- This conformational change exposes the reactive internal thioester bond.
- Membrane Attachment: Exposed $C3b$ must bind immediately to nucleophilic sites on activating target membranes (such as bacterial LPS, viral coats, or immune complexes).
- Unbound Fate: If no activating membrane is immediately proximate, continuing hydrolysis by ambient water inactivates the bond, preventing off-target host tissue destruction.
- Diversity of Cleavage Products: Unbound or regulated $C3b$ is sequentially degraded into a spectrum of inactive or immunomodulatory fragments, including $C3a$ , $C3b$ , $iC3b$ , $C3dg$ , and $C3d$ .
Formation of the C5 Convertases:
- When the density of newly cleaved $C3b$ increases on the activating membrane, a $C3b$ molecule binds directly into the existing $C3\text{ convertase}$ complexes, shifting their substrate specificity from $C3$ to $C5$ :
  - Classical and Lectin Pathway $C5\text{ Convertase}$ : Formed by the addition of $C3b$ to $C4b2a$ , generating the trimolecular complex $C4b2a3b$ .
  - Alternative Pathway $C5\text{ Convertase}$ : Formed by the addition of $C3b$ to $C3bBb$ , generating the complex $C3bBb3b$ .
Cleavage of Factor C5:
- $C5\text{ convertases}$ bind and cleave circulating native $C5$ :
  - $C5a$ : A small, potent peptide that diffuses away as a soluble anaphylatoxin into the circulation.
  - $C5b$ : The large cleavage fragment. Unlike $C3b$ and $C4b$ , $C5b$ lacks an internal thioester bond. Instead, upon cleavage, it exposes a transient hydrophobic binding region, dissociates from the convertase enzyme, and anchors hydrophobically directly to the lipid bilayer of the activating membrane adjacent to the convertase site.
Sequential Assembly of the Terminal Membrane Attack Complex (MAC / CAM):
- Recruitment of $C6$ and $C7$ : Membrane-bound $C5b$ acts as a high-affinity docking site that sequentially captures circulating $C6$ and $C7$ , assembling the lipophilic trimeric complex $C5b67$ .
- Insertion of $C8$ : The $C5b67$ complex binds native $C8$ . The $C8$ molecule possesses strongly hydrophobic properties, enabling it to penetrate deeply into the hydrophobic core of the host or microbial lipid bilayer to form $C5b678$ .
- Polymerization of $C9$ : The membrane-embedded $C5b678$ complex coordinates the sequential binding, unfolding, and polymerization of multiple ( $10\text{ to }16$ ) monomers of circulating $C9$ .
- Transmembrane Pore Formation: Polymerized $C9$ forms a rigid, circular, hollow transmembrane channel (pore diameter of approximately $10\text{--}16\,\text{nm}$ ) through the lipid membrane.
- Mechanism of Cell Death: These continuous pores allow the uncontrolled, bidirectional influx of extracellular water and ions ( $Na^+$ ) driven by colloid-osmotic pressure, resulting in rapid cellular swelling and osmotic lysis.

Regulatory Mechanisms: Soluble and Membrane-Bound Complement Inhibitors

The Critical Requirement for Regulation:
- Because the complement cascade is an explosive, self-amplifying enzymatic process capable of lysing eukaryotic membranes, unchecked or inappropriate activation can cause severe autologous tissue destruction, systemic inflammation, or death.
- Protection relies on two primary layers of control: the intrinsic instability (very short functional half-lives) of activated convertases and a complex network of soluble and membrane-associated regulatory proteins.

Overview of soluble regulatory factors acting across the complement pathways and the MAC

Soluble (Circulating) Regulatory Factors:
- $C1\text{-INH}$ (C1 Inhibitor):
  - A circulating plasma serine protease inhibitor (serpin) that selectively targets the classical and lectin pathways.
  - Physically binds to active $C1r$ and $C1s$ catalytic subunits, dissociating them from the central $C1q$ scaffold and preventing the cleavage of native $C4$ .
  - Exerts an equivalent inhibitory blockade against active $MASP\text{-}1$ and $MASP\text{-}2$ within the lectin pathway.
- $\text{sMAP}$ (Small MBL-Associated Protein) and $\text{MAP1}$ : Circulating splice variants that competitively compete with functional MASPs for binding to MBL, preventing initiation of the lectin cascade.
- $\text{C4bp}$ (C4-Binding Protein):
  - A high-molecular-weight plasma regulatory protein specific to the classical and lectin pathways.
  - Binds constitutively to $C4b$ , sterically hindering its interaction with $C2$ , accelerating the dissociation (decay) of the classical $C3\text{ convertase}$ ( $C4b2a$ ), and serving as a necessary cofactor for Factor I-mediated cleavage of $C4b$ .
- Factor I ( $\text{Fact I}$ ):
  - A circulating serine protease that inactivates both the classical, lectin, and alternative pathways.
  - Cleaves membrane-bound or soluble $C4b$ into inactive fragments, permanently preventing convertase assembly.
  - Cleaves and degrades $C3b$ into inactive derivatives ( $iC3b$ , $C3dg$ , $C3d$ ).
  - Clinical Significance of Factor I Deficiency: Genetic or acquired deficiency in Factor I leads to uncontrolled, continuous consumption of native $C3$ , a paradoxical secondary depletion of serum $C3$ , accumulation of unanchored $C3b$ , and severe susceptibility to recurrent bacterial infections.
- Factor H ( $\text{Fact H}$ ):
  - The primary soluble negative regulator of the alternative pathway.
  - Competes directly with Factor B for binding to surface-deposited $C3b$ , actively displacing $Bb$ from formed $C3bBb$ complexes (decay-accelerating activity).
  - Acts as an obligatory cofactor enabling Factor I to cleave and degrade $C3b$ .
- Vitronectin ( $\text{Vn}$ / Protein S):
  - A soluble inhibitor of terminal pathway assembly.
  - Binds to the fluid-phase, hydrophobic $C5b67$ complex, sterically preventing its membrane insertion, and directly hinders the subsequent incorporation of $C8$ and the polymerization of $C9$ , preventing fluid-phase MAC formation.
- $\text{SP40,40}$ (Clusterin): A circulating chaperone protein that associates directly with the assembling terminal MAC complex, restricting pore formation to dysfunctional, non-lytic micro-pores.
Membrane-Bound Regulatory Factors (Self vs. Non-Self Discrimination):
- Host cell membranes express high densities of specialized complement-inhibitory receptors, allowing complement to destroy foreign targets while sparing autologous cells.
- MCP (Membrane Cofactor Protein / $\text{CD46}$ ):
  - Expressed broadly on virtually all nucleated human cells and circulating blood cells, but notably absent on mature human erythrocytes (red blood cells).
  - Binds autologous membrane-deposited $C3b$ and $C4b$ , preventing convertase formation, and acts as an essential membrane-bound cofactor for Factor I-mediated proteolytic cleavage.
- DAF (Decay-Accelerating Factor / $\text{CD55}$ ):
  - A regulatory glycoprotein anchored to host cell outer membranes via a glycosylphosphatidylinositol (GPI) phosphatidylinositol lipid tail.
  - Expressed ubiquitously across all circulating peripheral blood cells.
  - Directly accelerates the structural dissociation and decay of assembled surface $C3\text{ convertases}$ ( $C4b2a$ and $C3bBb$ ), preventing downstream cascade amplification on host cell membranes.
- HRF (Homologous Restriction Factor) and $\text{CD59}$ (Protectin):
  - GPI-anchored membrane glycoproteins expressed widely on healthy host cells.
  - Physically incorporates into assembling membrane-associated $C5b\text{--}8$ complexes, directly arresting the recruitment, binding, and polymerization of $C9$ monomers, preventing functional lytic pore formation.
- CR1 (Complement Receptor 1 / $\text{CD35}$ ):
  - A multifunctional membrane glycoprotein that acts as both a regulatory inhibitor (accelerating convertase decay and acting as a cofactor for Factor I) and an opsonin receptor mediating phagocytic uptake.

Biological Functions and Receptor-Mediated Effector Pathways

Classification of Biological Effector Functions:
- 1. Direct Lytic Activity: Carried out by the physical insertion of the Membrane Attack Complex (MAC / CAM).
- 2. Pro-inflammatory and Immunomodulatory Activity: Mediated by cleavage products acting via specialized cell-surface complement receptors, divided into Opsonins and Anaphylatoxins.

Comprehensive map of complement activation and biological effector functions

1. Direct Cytolytic Action (MAC-Mediated Lysis):
- Mechanism: Insertion of multiple $C5b\text{--}9$ cylindrical channels disrupts membrane integrity, driving osmotic water influx and cell rupture.
- Susceptibility of Microbial Targets:
  - Gram-Negative Bacteria: Highly sensitive to MAC lysis due to their thin peptidoglycan layer and exposed outer lipid bilayer.
  - Gram-Positive Bacteria: Highly resistant to MAC lysis because their thick outer peptidoglycan wall prevents the MAC from reaching and penetrating the inner plasma membrane.
  - Viruses: Highly effective at destroying enveloped viruses by disrupting their lipid bilayer coats; naked (non-enveloped) viruses lack a lipid membrane and are practically unaffected by MAC.
- Resistance of Nucleated and Tumor Cells: Normal host nucleated cells and neoplastic/tumor cells show marked resistance to MAC lysis due to high surface expression of membrane inhibitors (CD46, CD55, CD59) and rapid active endocytic removal or shedding of membrane pores.
2. Opsonization and Phagocytic Clearance:
- Mechanism of Opsonization: Cleavage products coat the outer surfaces of pathogens, neutralizing electrostatic repulsion and providing high-affinity ligands for phagocytic receptors on effector leukocytes.
- Complement Receptor 1 (CR1 / $\text{CD35}$ ):
  - Exists in four distinct structural polymorphic isoforms across all peripheral blood cells.
  - Ligands: Binds with high affinity to membrane-deposited $C3b$ and $C4b$ .
  - Role in Phagocytosis: Expressed on monocytes, macrophages, and neutrophils, bringing opsonized pathogens into physical contact with phagocytic cells to trigger engulfment.
  - Clairance of Immune Complexes: Expressed abundantly on circulating erythrocytes (red blood cells) and platelets. Red blood cells capture circulating soluble antigen-antibody-complement complexes via CR1 and transport them safely through the circulation to the liver and spleen, where resident tissue macrophages (Kupffer cells) strip and destroy the complexes without damaging the carrier erythrocytes.
- Complement Receptor 2 (CR2 / $\text{CD21}$ ):
  - Ligands: Recognizes downstream breakdown products of $C3$ , specifically $C3d$ and $C3dg$ .
  - Cellular Distribution and Role: Expressed almost exclusively on the surface of B lymphocytes as a core component of the B-cell co-receptor complex (CD19/CD21/CD81). Simultaneous cross-linking of the B-cell receptor (BCR) and CD21 by complement-tagged antigens dramatically lowers the threshold required for B-lymphocyte activation, massively amplifying specific antibody production.
- Complement Receptors 3 and 4 (CR3 / $\text{Mac-1}$ / $\text{CD11b/CD18}$ and CR4 / $\text{CD11c/CD18}$ ):
  - Ligand: Specifically recognize the inactive cleavage fragment $iC3b$ .
  - Expression and Function: Expressed on professional phagocytes (macrophages, monocytes, polymorphonuclear neutrophils) and natural killer (NK) cells, stimulating potent phagocytic ingestion of targets.
- Antiviral Effector Roles of Opsonins: Complement opsonization drives extensive physical cross-linking and aggregation of virions, mechanically preventing viral attachment and cellular entry, while facilitating the destruction of virus-infected host cells.
3. Anaphylatoxins and Inflammatory Amplification:
- The Anaphylatoxin Peptides: Small, diffusible proteolytic fragments released during activation, consisting of $C5a$ (the most potent biological effector), followed in potency by $C3a$ and weakly by $C4a$ .
- Receptor Signaling: Anaphylatoxins exert their biological actions by binding to high-affinity, seven-transmembrane-domain G-protein-coupled receptors (GPCRs), most prominently the $C5a\text{ receptor}$ ( $C5aR$ ), triggering downstream intracellular calcium mobilization and kinase cascades.
- Biological Actions on Target Cells:
  - Mast Cells and Basophils: Triggers rapid degranulation and release of histamine and vasoactive amines.
  - Vascular Endothelial Cells: Increases vascular permeability and induces local vasodilation, facilitating fluid extravasation, plasma protein exudation, and tissue edema.
  - Vascular Smooth Muscle Cells: Directly induces smooth muscle contraction.
  - Polymorphonuclear Neutrophils and Monocytes: Acts as a powerful chemotactic factor that directs the polarized migration (chemotaxis) of granulocytes toward the site of infection, simultaneously upregulating leukocyte adhesion molecules and triggering the release of cytotoxic granular contents.

Non-Canonical Functions and Clinical Implications in Pathology

Immune Surveillance and Apoptosis Clearance:
- The complement system serves as a continuous, systemic surveillance apparatus, operating at the interface of innate and adaptive immunity.
- It differentiates between healthy self-surfaces and altered non-self, playing an indispensable role in recognizing and clearing apoptotic bodies and self-cellular debris without triggering an inflammatory autoimmune response.
Synaptogenesis and Central Nervous System Homeostasis:
- Beyond peripheral immunity, classical complement components ( $C1q$ and $C3$ ) are expressed locally in the developing and adult central nervous system.
- They tag immature, weak, or redundant neural synapses for elimination by resident phagocytic microglia (synaptic pruning), preserving structural and functional neurological homeostasis.
Metabolic and Adipocyte Regulation:
- Complement factors participate directly in the regulation of lipid metabolism within peripheral adipocytes (fat cells), influencing metabolic storage and energy homeostasis.
Dual Roles in Tumorigenesis:
- Antitumor Activity: Complement can assemble the MAC on malignant cells, mediating targeted tumor cell cytotoxicity (though this efficacy is frequently reduced by tumor-mediated upregulation of surface CD46, CD55, and CD59).
- Pro-Tumorigenic Progression: Sustained, low-level complement activation within the tumor microenvironment can paradoxically promote tumor growth. In early stages of neoplastic transformation, complement-driven inflammation recruits immunosuppressive myeloid cells, remodels the extracellular matrix, stimulates angiogenesis, and promotes cancer cell proliferation.
Septicemia and the Cytokine Storm ("Orage Cytokinique"):
- In systemic bacterial infections and sepsis, massive, uncontrolled systemic hyperactivation of the complement cascade takes place.
- Unchecked production of anaphylatoxins, particularly $C5a$ , drives a catastrophic release of pro-inflammatory cytokines ("cytokine storm" or orage cytokinique).
- This leads to generalized vascular leakage, widespread endothelial barrier breakdown, disseminated intravascular coagulation, profound refractory hypotension, multi-organ failure, and septic shock.
Induction of Peripheral Immune Tolerance via C1q:
- Independent of its cascade-activating properties, $C1q$ exerts an essential negative regulatory function to maintain systemic immunological tolerance.
- Mechanism of LAIR-1 Binding: Extracellular $C1q$ binds to $\text{LAIR-1}$ (Leukocyte-Associated Immunoglobulin-Like Receptor 1), an inhibitory immunoreceptor expressed on the surface of dendritic cell precursors.
- Suppression of Maturation: Engagement of LAIR-1 activates intracellular protein phosphatases that dephosphorylate and block positive activating kinase pathways, suppressing dendritic cell activation and maturation.
- Absence of T-Cell Priming: Immature dendritic cells fail to upregulate co-stimulatory molecules or present foreign/self antigens productively to T lymphocytes.
- Outcome: T-cell activation signals are withheld, preventing autoreactive T-cell priming and preserving self-tolerance.